Search results
5 days ago · With careful reporting and expert-written commentary, this special report explores advances that could delay or even prevent dementia and intriguing new approaches to support brain health in the...
4 days ago · For the first time, scientists have unraveled the structure of proteins in the brains of patients with Alzheimer's disease. The findings provide clues into how these disease-causing proteins...
1 day ago · Tue, July 16, 2024, 12:44 AM EDT · 3 min read. Cell death. Proteins found on the surface of animal cells and in between them could be a target for drugs to stop Alzheimer's in its earliest stages ...
2 days ago · The test scores showed that, on average, patients with mild cognitive impairment started with a score of 26.4, declining to 21 after five years. But patients with mild dementia dropped from 22.4 to 7.8 in five years, a much faster progression. The researchers were also able to model the effects of medication.
5 days ago · Researchers from the University of Cambridge have pinpointed the progression Alzheimer's in the brain. This discovery could lead to new treatments for the disease which affects an estimated...
- 1 min
- Money Talks News
2 days ago · The Alzheimer’s Association is the largest non-profit funder of Alzheimer’s disease research. Its mission is “to eliminate Alzheimer’s disease through the advancement of research; to provide and enhance care and support for all affected; and to reduce the risk of dementia through the promotion of brain health”. ISTAART; AAIC Conference
People also ask
Can proteins help treat Alzheimer's disease?
Is there a cure for Alzheimer's?
Can a predictive model predict Alzheimer's disease?
Could a protein stop Alzheimer's in the earliest stages?
5 days ago · The Food and Drug Administration approved a new Eli Lilly drug this month that treats Alzheimer’s disease. Kisunla is an IV infusion therapy given once a month to people in the early stages of Alzheimer’s, according to the Alzheimer’s Association.